NCT01490619

Brief Summary

Adolescents with type 1 diabetes are at increased risk for depressive symptoms, poor coping and problem-solving skills, poor regimen adherence, and negative diabetes-specific health outcomes. Although a handful of psychological interventions targeting adolescents' poor behavioral and emotional functioning demonstrate beneficial effects on disease management and outcomes, no prevention programs exist that equip adolescents with behavioral skills and cognitive strategies necessary to reduce these risks. Therefore, the proposed research will test whether a diabetes-specific adaptation of a resilience promoting, depression-prevention intervention for adolescents with type 1 diabetes will reduce both the risk of poor psychological functioning and the risk of negative health outcomes over time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
280

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 7, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 13, 2011

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2018

Completed
Last Updated

January 27, 2020

Status Verified

January 1, 2020

Enrollment Period

4.9 years

First QC Date

December 7, 2011

Last Update Submit

January 24, 2020

Conditions

Keywords

Type 1 diabetesAdolescentResiliencePreventionDepression

Outcome Measures

Primary Outcomes (1)

  • Change in Depressive symptoms from baseline to post intervention and change in Depressive symptoms over the two year study period.

    Investigators expect that Depressive symptoms will change over time. Specifically, it is expected that depressive symptoms will not increase and may even decrease in the Healthy Thinking in Teens arm, whereas depressive symptoms will increase in the Advanced Diabetes Education arm.

    baseline, 4.5 months, 8.5 months, 12.5 months, 16.5 months, and 28.5 months

Secondary Outcomes (1)

  • Change in Glycemic Control from baseline to post-intervention and change in Glycemic Control over time during the two year study period.

    baseline, 4.5 months, 8.5 months, 12.5 months, 16.5 months and 28.5 months

Study Arms (2)

Healthy Thinking in Teens

EXPERIMENTAL

Group-based, manualized program, based on cognitive behavioral therapy techniques.

Behavioral: Healthy Thinking In Teens

Advanced Diabetes Education

ACTIVE COMPARATOR

Group-based, manualized program designed to provide diabetes education, focused on adolescent-specific topics.

Other: Advanced Diabetes Education.

Interventions

9 sessions. Manualized and group based program. Each session lasts 90 minutes. Sessions occur approximately every other week.

Healthy Thinking in Teens

9 sessions. Manualized and group based program. Each session lasts 90 minutes. Sessions occur approximately every other week.

Advanced Diabetes Education

Eligibility Criteria

Age14 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • years old,
  • diagnosis of T1D according to ADA criteria for at least 1 year,
  • daily insulin dosing of at least 0.5 units per kilogram per day,
  • fluent in English, and
  • provide assent to participate.

You may not qualify if:

  • other chronic, physical disease or condition except for celiac or thyroid disease,
  • diagnosis of major depressive disorder determined at screening visit,
  • current treatment with an antidepressant,
  • diagnosis of major mental disorder (e.g., bipolar disorder, thought disorder, anorexia nervosa),
  • diagnosis of developmental disorder (e.g., mental retardation, autism, asperger's), or ward of the state.
  • Adolescents must have established T1D, uncomplicated by other chronic diseases so any observed changes in glycemic control during the study cannot be attributed to other diseases or to endogenous insulin production seen in the 'honeymoon' period.28 Adolescents cannot have a diagnosis of major depressive disorder because that diagnosis warrants more intensive intervention. Further, adolescents cannot be on antidepressant medication treatment at the time they start the trial because it may impact psychological outcomes and cause unmeasured treatment effects. Finally, adolescents need to be without developmental or learning problems as that may make participation difficult, especially in a group format.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ann and Robert H Lurie Children's Hospital of Chicago

Chicago, Illinois, 60611, United States

Location

Related Publications (2)

  • Shapiro JB, Bryant FB, Holmbeck GN, Hood KK, Weissberg-Benchell J. Do baseline resilience profiles moderate the effects of a resilience-enhancing intervention for adolescents with type I diabetes? Health Psychol. 2021 May;40(5):337-346. doi: 10.1037/hea0001076.

  • Hood KK, Iturralde E, Rausch J, Weissberg-Benchell J. Preventing Diabetes Distress in Adolescents With Type 1 Diabetes: Results 1 Year After Participation in the STePS Program. Diabetes Care. 2018 Aug;41(8):1623-1630. doi: 10.2337/dc17-2556. Epub 2018 Jun 19.

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Depression

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System DiseasesBehavioral SymptomsBehavior

Study Officials

  • Jill Weissberg-Benchell, PhD

    Ann & Robert H Lurie Children's Hospital of Chicago

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Psychologist, Department of Psychiatry

Study Record Dates

First Submitted

December 7, 2011

First Posted

December 13, 2011

Study Start

October 1, 2011

Primary Completion

September 1, 2016

Study Completion

March 30, 2018

Last Updated

January 27, 2020

Record last verified: 2020-01

Locations